HealthQuill disease progression
Switzerland’s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of patients with a rare type of kidney disease.
Drugs Health Pharma

Novartis’s drug to treat rare kidney disease gets USFDA approval 

Switzerland’s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of.

Read More
ALS
Drugs Health Medical

Parkinson’s drug Ropinirole shows promise as potential treatment for ALS, study finds

HQ Team June 7, 2023: Ropinirole, a drug already approved for the treatment of Parkinson’s disease, has shown potential as a treatment for.

Read More
X